CVE-2023-34626
Piwigo 13.7.0 is vulnerable to SQL Injection via the "Users" function.
CVE-2023-34626 is a medium vulnerability (CVSS 4.3) in Piwigo, published June 15, 2023. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.55%, the 46th percentile. No source names a fixed version.
- Severity
- 4.3 MediumCVSS 3.1, NVD
- Exploit chance
- 0.55%EPSS, 46th percentile
- Exploitation
- None knownNot on CISA’s or ENISA’s lists
- Fixed in
- No fix listedNo source names one
Description
Piwigo 13.7.0 is vulnerable to SQL Injection via the "Users" function.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- None
What an attacker can affect
- Confidentiality
- Low
- Integrity
- None
- Availability
- None
Exploit likelihood
Affected products
What each source reports
NVD Score used
Piwigo 13.7.0 is vulnerable to SQL Injection via the "Users" function.
- Record
CVE-2023-34626- CVSS 3.1
- 4.3 Medium
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N - Weakness
- CWE-89
- Updated
- 2026-11-02
CVE ListNo score
Piwigo 13.7.0 is vulnerable to SQL Injection via the "Users" function.
- Record
CVE-2023-34626- Updated
- 2026-11-02
EUVDEUVD-2023-38670No score
Piwigo 13.7.0 is vulnerable to SQL Injection via the "Users" function.
- Record
EUVD-2023-38670- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-g8rr-g77c-8v8c
Piwigo 13.7.0 is vulnerable to SQL Injection via the "Users" function.
Piwigo 13.7.0 is vulnerable to SQL Injection via the "Users" function.
- Record
GHSA-g8rr-g77c-8v8c- CVSS 3.1
- 4.3 Medium
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N - Weakness
- CWE-89
- Updated
- 2026-11-02
OSVNo score
Piwigo 13.7.0 is vulnerable to SQL Injection via the "Users" function.
- Record
CVE-2023-34626- Updated
- 2026-11-02
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD, OSV |
Dates are when Every CVE recorded each change. Upstream dates may differ.